Paul Awolade
6PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 17, 2024
CHD1L Inhibitor OTI-611 Synergizes with Chemotherapy to Enhance Antitumor Efficacy and Prolong Survival in Colorectal Cancer Mouse Models.Rita Sala, Hector Esquer, Timothy Kellett
|Aug 29, 2024
CHD1L Regulates Cell Survival in Breast Cancer and Its Inhibition by OTI-611 Impedes the DNA Damage Response and Induces PARthanatos.Rita Sala, Hector Esquer, Timothy Kellett
|Aug 14, 2024
TRPA1 Inhibition Effects by 3-Phenylcoumarin Derivatives.Carita Sallomy, Paul Awolade, Minna Rahnasto-Rilla
|Aug 26, 2022
α-Glucosidase and α-Amylase Inhibitory Potentials of Quinoline-1,3,4-oxadiazole Conjugates Bearing 1,2,3-Triazole with Antioxidant Activity, Kinetic Studies, and Computational Validation.Nosipho Cele, Paul Awolade, Pule Seboletswe
|May 02, 2022
Synthesis and in vitro anti-proliferative evaluation of naphthalimide-chalcone/pyrazoline conjugates as potential SERMs with computational validation.Shalini, Pankaj, Sourav Taru Saha
|Feb 22, 2022
Design, Synthesis, and Biological Evaluation of the First Inhibitors of Oncogenic CHD1L.Brett J Prigaro, Hector Esquer, Qiong Zhou
Pageof 1
Frequent Collaborators
2 joint publications
Daniel V LaBarbera
2 joint publications
Hector Esquer
1 joint publications
Vipan Kumar
1 joint publications
Nosipho Cele
1 joint publications
Pule Seboletswe
1 joint publications
Kolawole Olofinsan
1 joint publications
Parvesh Singh
1 joint publications
Minna Rahnasto-Rilla
1 joint publications
Niklas G Johansson
1 joint publications
Petri Turhanen
